0 Ratings

ID

31261

Description

To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00662896

Link

https://clinicaltrials.gov/show/NCT00662896

Keywords

  1. 8/5/18 8/5/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

August 5, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Osteoarthritis NCT00662896

    Eligibility Osteoarthritis NCT00662896

    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    men/women, 40 or older, diagnosed with hip or knee osteoarthritis.
    Description

    Age | Osteoarthritis of hip | Osteoarthritis, Knee

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    UMLS CUI [2]
    C0029410
    UMLS CUI [3]
    C0409959
    hypertensive patient with treated and controlled essential hypertension.
    Description

    Hypertensive disease | Essential Hypertension Treated | Essential Hypertension Controlled

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0020538
    UMLS CUI [2,1]
    C0085580
    UMLS CUI [2,2]
    C1522326
    UMLS CUI [3,1]
    C0085580
    UMLS CUI [3,2]
    C2911690
    must receive at least one antihypertensive treatment from the following drug classes: diuretic, angiotensin-converting enzyme (ace) inhibitor, angiotensin receptor blockers (arb) or beta-blocker (bb).
    Description

    Antihypertensive therapy Quantity | Diuretics | Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist | Adrenergic beta-Antagonists

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0585941
    UMLS CUI [1,2]
    C1265611
    UMLS CUI [2]
    C0012798
    UMLS CUI [3]
    C0003015
    UMLS CUI [4]
    C0521942
    UMLS CUI [5]
    C0001645
    must be current chronic user of nsaids or acetaminophen.
    Description

    NSAIDs chronic | Acetaminophen chronic

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0003211
    UMLS CUI [1,2]
    C0205191
    UMLS CUI [2,1]
    C0000970
    UMLS CUI [2,2]
    C0205191
    must discontinue all analgesic therapy at screening.
    Description

    Analgesic therapy To be stopped

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0412784
    UMLS CUI [1,2]
    C1272691
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    more than two different classes of antihypertensive drugs.
    Description

    Antihypertensive Agents Class Quantity

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0003364
    UMLS CUI [1,2]
    C0456387
    UMLS CUI [1,3]
    C1265611
    uncontrolled diabetes.
    Description

    Diabetic - poor control

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0421258
    hepatic or renal impairment.
    Description

    Hepatic impairment | Renal Insufficiency

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0948807
    UMLS CUI [2]
    C1565489
    a history of alcohol/drug abuse.
    Description

    Substance Use Disorders

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0038586
    diagnosis of gastric or duodenal ulceration and/or history of significant gastro-duodenal bleeding.
    Description

    Gastric ulcer | Duodenal Ulcer | Gastroduodenal haemorrhage

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0038358
    UMLS CUI [2]
    C0013295
    UMLS CUI [3]
    C1096494
    history of congestive heart failure.
    Description

    Congestive heart failure

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0018802
    clinically relevant abnormal ecg.
    Description

    ECG abnormal

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0522055
    current or history of a medical disease that could interfere with the study objectives or put the patient's safety at risk.
    Description

    Disease Interferes with Study Protocol | Disease At risk Patient safety

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0012634
    UMLS CUI [1,2]
    C0521102
    UMLS CUI [1,3]
    C2348563
    UMLS CUI [2,1]
    C0012634
    UMLS CUI [2,2]
    C1444641
    UMLS CUI [2,3]
    C1113679
    current or expected use of anticoagulants.
    Description

    Anticoagulants | Anticoagulants Expected

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0003280
    UMLS CUI [2,1]
    C0003280
    UMLS CUI [2,2]
    C1517001
    participation within 30 days prior to pre-screening in another investigational study.
    Description

    Study Subject Participation Status | Clinical Trial

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C2348568
    UMLS CUI [2]
    C0008976

    Similar models

    Eligibility Osteoarthritis NCT00662896

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Age | Osteoarthritis of hip | Osteoarthritis, Knee
    Item
    men/women, 40 or older, diagnosed with hip or knee osteoarthritis.
    boolean
    C0001779 (UMLS CUI [1])
    C0029410 (UMLS CUI [2])
    C0409959 (UMLS CUI [3])
    Hypertensive disease | Essential Hypertension Treated | Essential Hypertension Controlled
    Item
    hypertensive patient with treated and controlled essential hypertension.
    boolean
    C0020538 (UMLS CUI [1])
    C0085580 (UMLS CUI [2,1])
    C1522326 (UMLS CUI [2,2])
    C0085580 (UMLS CUI [3,1])
    C2911690 (UMLS CUI [3,2])
    Antihypertensive therapy Quantity | Diuretics | Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist | Adrenergic beta-Antagonists
    Item
    must receive at least one antihypertensive treatment from the following drug classes: diuretic, angiotensin-converting enzyme (ace) inhibitor, angiotensin receptor blockers (arb) or beta-blocker (bb).
    boolean
    C0585941 (UMLS CUI [1,1])
    C1265611 (UMLS CUI [1,2])
    C0012798 (UMLS CUI [2])
    C0003015 (UMLS CUI [3])
    C0521942 (UMLS CUI [4])
    C0001645 (UMLS CUI [5])
    NSAIDs chronic | Acetaminophen chronic
    Item
    must be current chronic user of nsaids or acetaminophen.
    boolean
    C0003211 (UMLS CUI [1,1])
    C0205191 (UMLS CUI [1,2])
    C0000970 (UMLS CUI [2,1])
    C0205191 (UMLS CUI [2,2])
    Analgesic therapy To be stopped
    Item
    must discontinue all analgesic therapy at screening.
    boolean
    C0412784 (UMLS CUI [1,1])
    C1272691 (UMLS CUI [1,2])
    Item Group
    C0680251 (UMLS CUI)
    Antihypertensive Agents Class Quantity
    Item
    more than two different classes of antihypertensive drugs.
    boolean
    C0003364 (UMLS CUI [1,1])
    C0456387 (UMLS CUI [1,2])
    C1265611 (UMLS CUI [1,3])
    Diabetic - poor control
    Item
    uncontrolled diabetes.
    boolean
    C0421258 (UMLS CUI [1])
    Hepatic impairment | Renal Insufficiency
    Item
    hepatic or renal impairment.
    boolean
    C0948807 (UMLS CUI [1])
    C1565489 (UMLS CUI [2])
    Substance Use Disorders
    Item
    a history of alcohol/drug abuse.
    boolean
    C0038586 (UMLS CUI [1])
    Gastric ulcer | Duodenal Ulcer | Gastroduodenal haemorrhage
    Item
    diagnosis of gastric or duodenal ulceration and/or history of significant gastro-duodenal bleeding.
    boolean
    C0038358 (UMLS CUI [1])
    C0013295 (UMLS CUI [2])
    C1096494 (UMLS CUI [3])
    Congestive heart failure
    Item
    history of congestive heart failure.
    boolean
    C0018802 (UMLS CUI [1])
    ECG abnormal
    Item
    clinically relevant abnormal ecg.
    boolean
    C0522055 (UMLS CUI [1])
    Disease Interferes with Study Protocol | Disease At risk Patient safety
    Item
    current or history of a medical disease that could interfere with the study objectives or put the patient's safety at risk.
    boolean
    C0012634 (UMLS CUI [1,1])
    C0521102 (UMLS CUI [1,2])
    C2348563 (UMLS CUI [1,3])
    C0012634 (UMLS CUI [2,1])
    C1444641 (UMLS CUI [2,2])
    C1113679 (UMLS CUI [2,3])
    Anticoagulants | Anticoagulants Expected
    Item
    current or expected use of anticoagulants.
    boolean
    C0003280 (UMLS CUI [1])
    C0003280 (UMLS CUI [2,1])
    C1517001 (UMLS CUI [2,2])
    Study Subject Participation Status | Clinical Trial
    Item
    participation within 30 days prior to pre-screening in another investigational study.
    boolean
    C2348568 (UMLS CUI [1])
    C0008976 (UMLS CUI [2])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial